Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 33 (Search time: 0.007 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2009Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse modelLabrinidis, A.; Hay, S.; Liapis, V.; Ponomarev, V.; Findlay, D.; Evdokiou, A.
2004Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicinBouralexis, S.; Clayer, M.; Atkins, G.; Labrinidis, A.; Hay, S.; Graves, S.; Findlay, D.; Evdokiou, A.
2000Expression of fibrillins and other microfibril-associated proteins in human bone and osteoblast-like cellsKitahama, S.; Gibson, M.; Hatzinikolas, G.; Hay, S.; Kuliwaba, J.; Evdokiou, A.; Atkins, G.; Findlay, D.
2003The relationship between RANKL expression and osteoblast differentiation in human osteoblastsKostakis, P.; Atkins, G.; Pan, B.; Farrugia, A.; Gronthos, S.; Evdokiou, A.; Findlay, D.; Zannettino, A.; European Symposium on Calcified Tissues (30th : 2003 : Rome, Italy)
2005RANK expression in normal and malignant cells: a monoclonal antibody studyKostakis, P.; Atkins, G.; Vincent, C.; Farrugia, A.; Findlay, D.; Evdokiou, A.; Zannettino, A.; Annual Meeting of the American Society for Bone and Mineral Research (27th : 2005 : Nashville, Tennessee)
2002Evidence for the maturation-dependent expression of an osteoclastogenic phenotype in human osteoblasts.Atkins, G.; Zannettino, A.; Kostakis, P.; Pan, B.; Farrugia, A.; Evdokiou, A.; Findlay, D.; American Society for Bone and Mineral Research. Conference (24th : 2002 : San Antonio, Texas)
2002Zoledronate is anabolic for human osteoblast-like cellsAtkins, G.; Pan, B.; Findlay, D.; To, L.; Evdokiou, A.; Labrinidis, A.; Bouralexis, S.; Zannettino, A.; American Society for Bone and Mineral Research. Conference (24th : 2002 : San Antonio, Texas)
1999Calcitonin Receptor-Mediated Growth Suppression of HEK-293 Cells is Accompanied by Induction of p21 WAF1/CIP1 and G2/M ArrestEvdokiou, A.; Raggatt, L.; Findlay, D.; Atkins, G.
2006The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAILButler, L.; Liapis, V.; Bouralexis, S.; Welldon, K.; Hay, S.; Thai, L.; Labrinidis, A.; Tilley, W.; Findlay, D.; Evdokiou, A.
2009Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myelomaLabrinidis, A.; Diamond, P.; Martin, S.; Hay, S.; Liapis, V.; Zinonos, I.; Sims, N.; Atkins, G.; Vincent, C.; Ponomarev, V.; Findlay, D.; Zannettino, A.; Evdokiou, A.